As of August 28, 2026, Eikon Therapeutics, Inc. (EIKN) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. Eikon Therapeutics, Inc. has a market capitalization of $586.86M, 54.17M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for EIKN.
Market Data
Market Cap$586.86M
Shares Outstanding54.17M
Float27.52M
Cash$531.18M
Debt$254.83M
Short InterestN/A
Institutional Holdings
73.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest4.88M
Days to Cover20.0
% of Float17.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2026-03-31
xbrl
XBRL WARRANT
2025-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual EIKN Dilution Snapshot
Eikon Therapeutics, Inc. (EIKN) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for EIKN: xbrl on 2026-03-31; xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track EIKN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EIKN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for EIKN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.